A
Advanced echocardiographic techniques 16
Albuminuria 82
Aldosterone antagonist therapy 61
Amino acid, branched-chain 83
Amyloid fibrils 3
Anemia 25
Antiapoptotic therapy 4
Antifibrotic therapies 37
Arterial lactate, level of 114
Artificial intelligence, application of 29
Atherosclerosis, multi-ethnic study of 53
Atrioventricular optimization trial 93
C
Canagliflozin, comparative effectiveness of 87
Cardiopulmonary bypass machine 114
Carnitine O-palmitoyltransferase 1 12
Catheter ablation 91
Central venous pressure 107
Chest pain, acute 42
Chronic diseases 73
Complex contraction pattern 17
Coronary disease 63
Cyclic guanosine 3′5′ monophosphate 39
D
DANISH trial 97
Dapagliflozin 79
Destination therapy 107
Device-registered arrhythmic events 77
Discoidin domain receptor 2 1
Diuretics 59
Dopamine 59
E
Edema 51
Electrocardiography 48
Electrophysiology 89
Elevated jugular venous pressure 67
Empagliflozin, cardiac benefits of 83
Enalapril 39
F
Fat, subcutaneous 50
Fatal bleeding 64
Fatty acid 11
Fatty liver disease, nonalcoholic 84
Ferric carboxymaltose 26
Fluorodeoxyglucose-positron emission tomography 52
Free fatty acid 83
H
Heart
disease 5
nonischemic 96
failure 2, 6, 8–15, 18, 20–23, 25–28, 31–34, 37–41, 45, 47, 48, 48f, 49, 50, 57, 59, 61, 63, 65, 73, 75, 77, 92
fat distribution in two types of 50
genesis of 10
guidelines 19
incident 46f
medical therapy, target doses of 22
metabolic switch in 14
postinfarction 4
prevention of 4
randomized evaluation of 59
risk 45
Society of America 22
stages 58f
sudden death in 60
treatment of 4
types of 49
function 7
donor predicted 102
rate 34
repair and function 1
Hemoglobin, glycated 86
Hepatic fat reduction 84
High-dose loop diuretics 69
Himachal Pradesh Heart Failure Registry 25
His bundle pacing 92
Hospital-acquired hyponatremia, incidence of 29
Hydroxyl and nitric oxide 15
Hypertension, pulmonary 16
I
Immune system cells 13
Immunoglobulin light-chain amyloidosis 3
Inflammation 48
Insulin secretion 13
Intensive care unit 103
International Ventricular Tachycardia Ablation Center Collaborative Study 96
Interventricular electrical delay, effects of 93
Intracardiac cardioverter defibrillator 89
Intravenous cardiovascular agents, long-term safety of 68
L
Lactate dehydrogenase 111
Left atrial reservoir strain 53
Left ventricular
therapy 108
assist implantation 111
dysfunction 91
electrograms 93
end-diastolic volume 54
function 89
malignant 53
Leukocyte 48
Lipoprotein, low-density 86
Lymphocytes 97
M
Machine learning methods 28
Matrix metalloproteinase-2 44
Metabolic flexibility 11
Metolazone, adjuvant 69
Microalbuminuria 76
Mid-range ejection fraction 33
Mitochondria 10
Muscle bundles, anomalous 49f
Mutant transthyretin 3
Myocardial fibrosis 54
Myocardial inflammation 48
Myocardial inflammatory diseases 89
Myocardial stress, biomarkers of 39
Myocardium 49f
Myofibroblast cells 1
P
Paradigm study 40
Peak global left atrial longitudinal strain 53f
Peak oxygen consumption 74
Percutaneous coronary intervention 57
Pericardial fat 50
Pneumococcal infections 66
Positron emission tomography computed tomography 48
Postheart transplant 104
Post-infarction left ventricular remodelling 12
Potassium 70
Premature ventricular contractions 95
R
Radial shortening 17
Randomization 83
Reactive oxygen species 14
Real-World Meta-Analysis of 4 Observational Databases 87
Renal dysfunction 76
Renal sodium retention 41
Right bundle branch block 92
Right ventricular
assist device 113
dysfunction 112
electrograms 93
function 16
mechanical pattern 16
support, temporary 111
Routine atrioventricular optimization 93
S
Sarcoidosis 52f
Sarcoplasmic reticulum 12
Seattle proportional risk model 97
Sinus rhythm 63
Skeletal muscle bioenergetics 52
Steady-state free precession 49f
Swedish Heart Failure Registry 28
T
T2-weighted short-tau inversion recovery 51f
Tissues, anatomy of 2
Tricuspid annular plane systolic excursion 17
T-wave inversion, anterior 94